The impact of the Ebola epidemic on the child vaccination rate.
Following 2019 rejection, FDA adcomm votes against Lexicon’s type 1 diabetes and CKD drug
For the second time in five years, an FDA advisory committee voted against endorsing the benefit-risk profile of Lexicon’s drug sotagliflozin. The Endocrinologic and Metabolic